Conjugate Vaccine

Conjugate vaccines represent a sophisticated approach to immunization, particularly effective against bacterial infections that are difficult to address with traditional vaccines. These vaccines work by linking a polysaccharide antigen from a bacterial capsule to a protein carrier, which enhances the immune system's ability to recognize and respond to the pathogen. This conjugation not only improves the vaccine's efficacy but also extends its protective effects to infants and young children, whose immune systems may not respond adequately to polysaccharide antigens alone.

 

    Related Conference of Conjugate Vaccine

    September 07-08, 2026

    38th Annual Congress on Vaccine and Clinical Trials

    London, UK
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain
    September 28-29, 2026

    8th World Congress on Vaccine and Immunology

    Toronto, Canada
    November 16-17, 2026

    7th International Conference on Vaccine Research

    Tokyo, Japan

    Conjugate Vaccine Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in